Catalyst Wire Dossier Catalyst Wire Dossier

aloselim

alirocumab · Sanofi
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for aloselim, covering 2019-06-13 to 2019-06-13. Get the full timeline:

Most recent: Clinical Trial Update: Early Alirocumab to Reduce LDL-C in Myocardial Infarction [Phase 4]

See pricing